Adage Capital files Schedule 13G showing 7.67% NextCure (NXTC) ownership
Adage Capital Management, L.P. and its affiliates have reported a 7.67% passive ownership stake in NextCure, Inc. (NXTC) through a Schedule 13G filing. The investment firm beneficially owns 277,202 shares of NextCure's common stock, based on 3,612,096 shares outstanding as of May 1, 2026. …